267 related articles for article (PubMed ID: 25589066)
21. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice.
McClellan SA; Huang X; Barrett RP; van Rooijen N; Hazlett LD
J Immunol; 2003 May; 170(10):5219-27. PubMed ID: 12734370
[TBL] [Abstract][Full Text] [Related]
22. TREM-2 promotes host resistance against Pseudomonas aeruginosa infection by suppressing corneal inflammation via a PI3K/Akt signaling pathway.
Sun M; Zhu M; Chen K; Nie X; Deng Q; Hazlett LD; Wu Y; Li M; Wu M; Huang X
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3451-62. PubMed ID: 23611998
[TBL] [Abstract][Full Text] [Related]
23. Effects of VIP on corneal reconstitution and homeostasis following Pseudomonas aeruginosa induced keratitis.
Berger EA; Vistisen KS; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7432-9. PubMed ID: 23036997
[TBL] [Abstract][Full Text] [Related]
24. NLRP12 promotes host resistance against Pseudomonas aeruginosa keratitis inflammatory responses through the negative regulation of NF-κB signaling.
Deng QC; Deng CT; Li WS; Shu SW; Zhou MR; Kuang WB
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8063-8075. PubMed ID: 30556841
[TBL] [Abstract][Full Text] [Related]
25. Role of the Fas pathway in Pseudomonas aeruginosa keratitis.
Zhou Z; Wu M; Barrett RP; McClellan SA; Zhang Y; Hazlett LD
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2537-47. PubMed ID: 20019368
[TBL] [Abstract][Full Text] [Related]
26. Corneal response to Pseudomonas aeruginosa infection.
Hazlett LD
Prog Retin Eye Res; 2004 Jan; 23(1):1-30. PubMed ID: 14766315
[TBL] [Abstract][Full Text] [Related]
27. The role of VIP in cornea.
Jiang X; McClellan SA; Barrett RP; Zhang Y; Foldenauer ME; Hazlett LD
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7560-6. PubMed ID: 23074208
[TBL] [Abstract][Full Text] [Related]
28. Interferon regulatory factor-1 in flagellin-induced reprogramming: potential protective role of CXCL10 in cornea innate defense against Pseudomonas aeruginosa infection.
Yoon GS; Dong C; Gao N; Kumar A; Standiford TJ; Yu FS
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7510-21. PubMed ID: 24130180
[TBL] [Abstract][Full Text] [Related]
29. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.
Hazlett LD; Huang X; McClellan SA; Barrett RP
Eye (Lond); 2003 Nov; 17(8):863-71. PubMed ID: 14631390
[TBL] [Abstract][Full Text] [Related]
30. TIPE2 Suppresses Pseudomonas aeruginosa Keratitis by Inhibiting NF-κB Signaling and the Infiltration of Inflammatory Cells.
Wang Q; Ma L; Liu T; Ge C; Zhou Q; Wei C; Shi W
J Infect Dis; 2019 Aug; 220(6):1008-1018. PubMed ID: 31067300
[TBL] [Abstract][Full Text] [Related]
31. HIF-1α is essential for effective PMN bacterial killing, antimicrobial peptide production and apoptosis in Pseudomonas aeruginosa keratitis.
Berger EA; McClellan SA; Vistisen KS; Hazlett LD
PLoS Pathog; 2013; 9(7):e1003457. PubMed ID: 23874197
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Pseudomonas aeruginosa corneal infection using an oligonucleotide microarray.
Huang X; Hazlett LD
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3409-16. PubMed ID: 12882789
[TBL] [Abstract][Full Text] [Related]
33. Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.
Hazlett LD; Rudner XL; McClellan SA; Barrett RP; Lighvani S
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):419-24. PubMed ID: 11818386
[TBL] [Abstract][Full Text] [Related]
34. IL-24 Promotes
Ross BX; Gao N; Cui X; Standiford TJ; Xu J; Yu FX
J Immunol; 2017 May; 198(9):3536-3547. PubMed ID: 28330899
[TBL] [Abstract][Full Text] [Related]
35. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
36. VIP promotes resistance in the Pseudomonas aeruginosa-infected cornea by modulating adhesion molecule expression.
Berger EA; McClellan SA; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5776-82. PubMed ID: 20592225
[TBL] [Abstract][Full Text] [Related]
37. VIP and growth factors in the infected cornea.
Jiang X; McClellan SA; Barrett RP; Berger EA; Zhang Y; Hazlett LD
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6154-61. PubMed ID: 21666233
[TBL] [Abstract][Full Text] [Related]
38. Mammalian target of rapamycin regulates IL-10 and resistance to Pseudomonas aeruginosa corneal infection.
Foldenauer ME; McClellan SA; Berger EA; Hazlett LD
J Immunol; 2013 Jun; 190(11):5649-58. PubMed ID: 23626014
[TBL] [Abstract][Full Text] [Related]
39. HMGB1 Antagonist, Box A, Reduces TLR4, RAGE, and Inflammatory Cytokines in the Cornea of P. aeruginosa-Infected Mice.
Ekanayaka SA; McClellan SA; Peng X; Barrett RP; Francis R; Hazlett LD
J Ocul Pharmacol Ther; 2018 Nov; 34(10):659-69. PubMed ID: 30407111
[TBL] [Abstract][Full Text] [Related]
40. IFN-gamma: regulation of nitric oxide in the P. aeruginosa-infected cornea.
McClellan SA; Lighvani S; Hazlett LD
Ocul Immunol Inflamm; 2006 Feb; 14(1):21-8. PubMed ID: 16507487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
